Literature DB >> 23883805

Common variable immunodeficiency.

Jonathan S Tam1, John M Routes.   

Abstract

Common variable immunodeficiency (CVID) is a common primary immunodeficiency characterized by a failure in B-cell differentiation with defective immunoglobulin production. Affected patients are uniquely susceptible to recurrent infection with encapsulated organisms and have an increased propensity for the development of inflammatory and autoimmune manifestations. The diagnosis of CVID is commonly delayed and the underlying cause of the disorder is not understood. Replacement antibody therapy reduces the risk of serious infections. However, optimal treatment regimens for the uncommon manifestations associated with this disease, such as granulomatous lymphocytic interstitial lung disease, require further research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23883805      PMCID: PMC3901442          DOI: 10.2500/ajra.2013.27.3899

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  88 in total

1.  Caseating granulomatous disease in common variable immunodeficiency treated with infliximab.

Authors:  Ammar Z Hatab; Zuhair K Ballas
Journal:  J Allergy Clin Immunol       Date:  2005-10-10       Impact factor: 10.793

2.  Oxcarbazepine-induced immunoglobulin deficiency.

Authors:  Adina Kay Knight; Charlotte Cunningham-Rundles
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

3.  Immune competence and switched memory B cells in common variable immunodeficiency.

Authors:  Jimmy Ko; Lin Radigan; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2005-07       Impact factor: 3.969

4.  Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature.

Authors:  Akaluck Thatayatikom; Sthorn Thatayatikom; Andrew J White
Journal:  Ann Allergy Asthma Immunol       Date:  2005-09       Impact factor: 6.347

5.  Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.

Authors:  U Salzer; H M Chapel; A D B Webster; Q Pan-Hammarström; A Schmitt-Graeff; M Schlesier; H H Peter; J K Rockstroh; P Schneider; A A Schäffer; L Hammarström; B Grimbacher
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

6.  TACI is mutant in common variable immunodeficiency and IgA deficiency.

Authors:  Emanuela Castigli; Stephen A Wilson; Lilit Garibyan; Rima Rachid; Francisco Bonilla; Lynda Schneider; Raif S Geha
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

Review 7.  Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines.

Authors:  Mark J Rosen
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

Review 8.  Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

Authors:  Jordan S Orange; Elham M Hossny; Catherine R Weiler; Mark Ballow; Melvin Berger; Francisco A Bonilla; Rebecca Buckley; Javier Chinen; Yehia El-Gamal; Bruce D Mazer; Robert P Nelson; Dhavalkumar D Patel; Elizabeth Secord; Ricardo U Sorensen; Richard L Wasserman; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

Review 9.  Granulomatous disease in common variable immunodeficiency.

Authors:  Yoshikazu Morimoto; John M Routes
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

10.  TACI and BAFF-R mediate isotype switching in B cells.

Authors:  Emanuela Castigli; Stephen A Wilson; Sumi Scott; Fatma Dedeoglu; Shengli Xu; Kong-Peng Lam; Richard J Bram; Haifa Jabara; Raif S Geha
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

View more
  14 in total

1.  Comprehensive Assessment of Skin Disorders in Patients with Common Variable Immunodeficiency (CVID).

Authors:  Ali Zarezadeh Mehrabadi; Nazanin Aghamohamadi; Hassan Abolhassani; Asghar Aghamohammadi; Nima Rezaei; Reza Yazdani
Journal:  J Clin Immunol       Date:  2022-01-27       Impact factor: 8.317

2.  Cerebral toxoplasmosis in a patient with combined variable immunodeficiency.

Authors:  Torrey Czech; Parthav Shah; Gunnar Lee; Gina Watanabe; Christian Ogasawara; Thomas Noh
Journal:  Surg Neurol Int       Date:  2022-08-12

Review 3.  Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis.

Authors:  Hamed Zainaldain; Fatema Sadaat Rizvi; Hosein Rafiemanesh; Mahla Alizadeh; Mahnaz Jamee; Sara Mohammadi; Fatemeh Kiaee; Hamed Mohammadi; Farhad Babaie; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Oman Med J       Date:  2020-07-30

4.  Late Onset Combined Immunodeficiency Presenting with Recurrent Pneumocystis jiroveci Pneumonia.

Authors:  Ilias Papakonstantinou; Ioannis G Baraboutis; Lazaros Karnesis
Journal:  Case Rep Med       Date:  2014-03-31

5.  A Novel de Novo Mutation in the CD40 Ligand Gene in a Patient With a Mild X-Linked Hyper-IgM Phenotype Initially Diagnosed as CVID: New Aspects of Old Diseases.

Authors:  Tábata T França; Luiz F B Leite; Tiago A Maximo; Christiane G Lambert; Nuria B Zurro; Wilma C N Forte; Antonio Condino-Neto
Journal:  Front Pediatr       Date:  2018-05-04       Impact factor: 3.418

6.  Characteristics of the patients followed with the diagnosis of common variable immunodeficiency and the complications.

Authors:  Semiha Bahceci Erdem; Nesrin Gulez; Ferah Genel; Sait Karaman; Hikmet T Nacaroglu
Journal:  Cent Eur J Immunol       Date:  2019-07-30       Impact factor: 2.085

7.  Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.

Authors:  Mathieu Amand; Gilles Iserentant; Aurélie Poli; Marwan Sleiman; Virginie Fievez; Isaura Pilar Sanchez; Nicolas Sauvageot; Tatiana Michel; Nasséra Aouali; Bassam Janji; Claudia Milena Trujillo-Vargas; Carole Seguin-Devaux; Jacques Zimmer
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561

Review 8.  The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.

Authors:  Ulrich Baumann; John M Routes; Pere Soler-Palacín; Stephen Jolles
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

9.  Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy.

Authors:  Rita Polito; Ersilia Nigro; Antonio Pecoraro; Maria Ludovica Monaco; Franco Perna; Alessandro Sanduzzi; Arturo Genovese; Giuseppe Spadaro; Aurora Daniele
Journal:  Front Immunol       Date:  2019-11-27       Impact factor: 7.561

10.  Atypical presentation of Good syndrome: acute hepatitis from hepatitis B virus reactivation.

Authors:  Yi Wye Lai; Teck-Choon Tan
Journal:  Asia Pac Allergy       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.